Related references
Note: Only part of the references are listed.Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature
Sarah Pericart et al.
VIRCHOWS ARCHIV (2020)
ALK-positive histiocytosis with KIF5B-ALK fusion in an adult female
Gaurav K. Gupta et al.
HAEMATOLOGICA (2019)
ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion
Kenneth Tou En Chang et al.
MODERN PATHOLOGY (2019)
Expanding the Phenotype of ALK-positive Histiocytosis: A Report of 2 Cases
Huiya Huang et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2018)
Bruton's tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma
Tianfeng Li et al.
ONCOGENE (2018)
ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy
Jeffrey S. Ross et al.
ONCOLOGIST (2017)
The clinical spectrum of Erdheim-Chester disease: an observational cohort study
Juvianee I. Estrada-Veras et al.
BLOOD ADVANCES (2017)
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
Eli L. Diamond et al.
CANCER DISCOVERY (2016)
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
J.-F. Emile et al.
BLOOD (2016)
Nurse-like cells mediate ibrutinib resistance in chronic lymphocytic leukemia patients
F. Boissard et al.
BLOOD CANCER JOURNAL (2015)
Clonally Related Follicular Lymphomas and Langerhans Cell Neoplasms
Dava S. West et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo
Sabine Ponader et al.
BLOOD (2012)
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Sarah E. M. Herman et al.
BLOOD (2011)
Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases
Haipeng Shao et al.
MODERN PATHOLOGY (2011)
ALK+ histiocytosis:: a novel type of systemic histiocytic proliferative disorder of early infancy
John K. C. Chan et al.
BLOOD (2008)
Share Paper
